Lawrence J. Cohen, PharmD

Department of Pharmacotherapy, University of North Texas Health College of Pharmacy; Fort Worth, Texas; Touro College of Pharmacy, Touro University, New York, New York

  • 12Articles
  • 18.1KReads
  • 1999–2026Active
  • 27Collaborators
  • 63Citations

About

Lawrence J. Cohen, PharmD, is affiliated with the Department of Pharmacotherapy at the University of North Texas Health College of Pharmacy and Touro College of Pharmacy at Touro University. Cohen has published extensively on topics including depression, psychopharmacology, anxiety, psychiatry, and sleep. His work addresses clinical issues such as treatment adherence and failure with monoamine oxidase inhibitors, patterns of use of selegiline transdermal system in major depressive disorder, and coverage of atypical antipsychotics in Medicare drug plans. Cohen has contributed to Psychiatrist.com from 1999 through 2026.

Publications

JCP
When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?
ASCP Corner

When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?

August 6, 2026

Focuses on descriptive symptom phenomenology and strategies to minimize discomfort during antidepressant cessation, with possible explanations for unusual, delayed, or protracted symptoms in patients for whom non-pharmacodynamic features may...
, , , et al
PCC
Brief Report

Selegiline Transdermal System: Use Pattern and Adherence in Patients With Major Depressive Disorder

February 21, 2013

Since adherence and health outcomes are strongly associated, Sclar and colleagues conducted a retrospective exploratory claims-based analysis to discern the pattern of use of selegiline transdermal system relative to...
, ,
JCP
Educational Activity

MAOIs: Issues in Treatment Adherence and Rates of Treatment Failure

January 15, 2013

,
JCP
Supplement Article

Discussion: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

July 27, 2012

, , , et al
JCP
Supplement Article

Introduction: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

July 27, 2012

,
JCP
Supplement Article

Issues in Adherence to Treatment With Monoamine Oxidase Inhibitors and the Rate of Treatment Failure

July 27, 2012

,
PCC
Article

Discussion: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

July 15, 2012

, , , et al
PCC
Article

Introduction: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

July 15, 2012

,
PCC
Article

Issues in Adherence to Treatment With Monoamine Oxidase Inhibitors and the Rate of Treatment Failure

July 15, 2012

,
PCC
Original Research

Coverage of Atypical Antipsychotics Among Medicare Drug Plans in the State of Washington: Changes Between 2007 and 2008

December 17, 2009

, , , et al
PCC
Original Research

Coverage of Atypical Antipsychotics Among Medicare Drug Plans in the State of Washington for Fiscal Year 2007

August 15, 2008

, , , et al
JCP
Article

The Role of Neuropsychiatric Pharmacists

August 1, 1999

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe